Tilray Brands, Inc. Contractual Obligation, to be Paid, Year Four
Tilray Brands, Inc. (TLRY) had Contractual Obligation, to be Paid, Year Four of $4.26 million as of 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInFourthYear · last filed 2026-07-28
- 2026-05-31: Contractual Obligation, to be Paid, Year Four $4.26M.
- 2026-02-28: Contractual Obligation, to be Paid, Year Four $4.28M.
- 2025-11-30: Contractual Obligation, to be Paid, Year Four $4.15M.
- 2025-08-31: Contractual Obligation, to be Paid, Year Four $3.53M.
| Period end | Contractual Obligation, to be Paid, Year Four |
|---|---|
| 2026-05-31 | $4.26M 10-K · filed 2026-07-28 |
| 2026-02-28 | $4.28M 10-Q · filed 2026-04-01 |
| 2025-11-30 | $4.15M 10-Q · filed 2026-01-08 |
| 2025-08-31 | $3.53M 10-Q · filed 2025-10-09 |
| 2025-05-31 | $3.49M 10-K · filed 2025-07-29 |
| 2025-02-28 | $85.20M 10-Q · filed 2025-04-08 |
| 2024-11-30 | $69.10M 10-Q · filed 2025-01-10 |
| 2024-08-31 | $66.76M 10-Q · filed 2024-10-10 |
| 2024-05-31 | $68.67M 10-K · filed 2024-07-30 |
| 2024-02-29 | $182.84M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $182.83M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $9.29M 10-Q · filed 2024-10-10 |
| 2023-05-31 | $10.52M 10-K · filed 2023-07-26 |
| 2023-02-28 | $4.98M 10-Q · filed 2023-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |